9.500
−5,00%
2026-07-29
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -46.2% | +186.4% | 2 / 3 | +32.9% | -1.25 pp | -0.36 pp | +2.2% | 0.59 | 39.06 | 30,1 | +32,9% | 0,1 | −48,6% | 39.06 | 48.48 | −19,4% |
| Pts | 0 | 12 | 8 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 9.500 (close price on 2026-07-29)EPS (TTM): 243,2
Financial charts
1.Revenue & growth
VND bn30,1Q2/26
1.Revenue & growth
VND bn30,1Q2/26
2.Profit & growth
VND bn0,06Q2/26
3.Profit mix (Penman)
VND bn0,78Q2/26
4.Margins & cost structure
%3.3%Q2/26
5.Returns & cash cycle
% · days1.8%Q2/26
6.Earnings quality & cash
VND bn21,2Q2/26
7.Asset structure
VND bn107Q2/26
8.Funding & debt health
VND bn · times107Q2/26
9.Revenue backlog
VND bn32,3Q2/26
10.Valuation
times · %39,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %21Q2/26
Adjusted EPS growth, latest quarter
-56.9%
Average adjusted EPS growth, 3 quarters
171%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26